MEDICIS PHARAMACEUTICAL CORPORATION SELECTS
Leading independent specialty
pharmaceutical company focusing on the treatment of dermatological
and aesthetic conditions selects clinivation WorldView as its most
comprehensive, authoritative, and up-to-date resource for building
its medical product submissions and registrations worldwide.
Natick, MA, September 02,
2010 - clinivation, Inc. announced today Medicis Pharmaceutical
Corporation has selected the clinivation WorldView enterprise solution
for On-Demand Global Regulatory Intelligence.
“Medicis Pharmaceutical is a leading independent specialty pharmaceutical
company focusing primarily on the treatment of dermatological and
aesthetic conditions. We are pleased that they have chosen clinivation
WorldView for comprehensive, authoritative, and up-to-date global
regulatory intelligence,” said Richard Morroney, R.A.C., C.Q.A.,
clinivation's Vice President, Global Market Clearance Solutions.
About clinivation WorldView On-Demand Global Regulatory Intelligence
Clinivation WorldView is the medical device and diagnostic industry's most comprehensive,
authoritative, and up-to-date enterprise solution for On-Demand Global Regulatory
Intelligence. Providing clear, step-by-step market clearance regulations, processes,
and guidance for >99% of the world markets, only clinivation WorldView delivers
tried-and-true intelligence from certified, practicing professionals with real-world
About Medicis Pharmaceutical Corporation
Medicis is the leading independent specialty pharmaceutical
company in the United States focusing primarily on the treatment
of dermatological and aesthetic conditions. The Company is dedicated
to helping patients attain a healthy and youthful appearance and
self-image. Medicis has leading branded prescription products in
a number of therapeutic and aesthetic categories. The Company's
products have earned wide acceptance by both physicians and patients
due to their clinical effectiveness, high quality and cosmetic elegance.
For more information about Medicis, please visit www.medicis.com
About clinivation, Inc.
is the leading provider of integrated solutions that enable global market clearance.
Guided by our singular vision - "Excellence in Market Clearance" - clinivation
accelerates the entire market clearance cycle to advance new worldwide revenue
and achieve new milestones of enterprise value.
Used in over 1,000,000 product
registrations by more than 100 companies worldwide, clinivation's end-to-end technology
and services deliver on our vision by eliminating revenue traps from global market
clearance operations, increasing process velocity with on-demand regulatory intelligence,
automating clearance-driven business controls, simplifying content unification
into market clearance applications, aligning quality systems with global market
clearance priorities, streamlining clinical development with clearance-focused
trials, and enabling management with key performance indicators for continuous
improvement and effective governance.
The world's leading medical device,
diagnostics, hospital supply, and dental supply companies select clinivation because
of our medtech industry focus and our unique, integrated solutions that seamlessly
adapt to existing business processes and enterprise infrastructure- without the
need to write custom code.
Our core brands include the clinivation Global xi
market clearance platform, clinivation WorldView on-demand regulatory intelligence,
and clinivation Clinical Suite and clinivation Registry Suite electronic data
capture and clinical data management software.
Founded in 1999, the company
is headquartered in Natick, Massachusetts, with regional offices in North America
Visit clinivation online at www.clinivation.com
For more information on clinivation's
integrated solutions that enable global market clearance, please click
or call us at 508.655.6560.